April 30, 2019
The company's sodium hyaluronate pharmaceutical raw material drug workshop was put into trial operation and officially put into operation.
End of 2018
The company's micro plastic injection preparation project was rated as the key project of Binzhou City 2019.
December 2018
The company obtained the NSF certificate.
End of 2017
The company's second phase expansion project was officially put into operation.
October 2016
The company obtained a drug production license.
Second half of 2016
The company's second-phase expansion project was rated as the key project of Binzhou City in 2016, and construction started in the second half of the year.
Second half of 2016
The company issued additional shares of 4.9 million shares and raised 27 million yuan.
Second half of 2015
The company will issue 3 million shares of the company and raise 15 million yuan.
8 June 2015
The company officially listed three boards.
February 2015
The company underwent joint-stock reform, formally renamed Shandong AWA Biopharm Co., Ltd.
2012
The company officially put into production.
July 2010
The company was formally established, and Binzhou Anhua Bioengineering Co., Ltd. was registered in Binzhou.